feed,title,long_url,short_url
Benzinga,Analyst Expects Derisking Required Ahead Of Patent Expiry For This Large Pharma/MedTech Stock,https://benzinga.com/analyst-ratings/analyst-color/22/11/29788522/analyst-expects-derisking-required-ahead-of-patent-expiry-for-this-large-pharmamedt,https://bit.ly/3AsgOrk
